Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 181 to 186 of 186 entries
Sorted by: Best Match Show Resources per page
Impact of Consensus Definitions on Identification of Glomerular Lesions by Light and Electron Microscopy.

Kidney international reports

Haas M, Mirocha J, Amann K, Bajema IM, Barisoni L, Becker JU, Jennette JC, Joh K, Ljubanovic DG, Roberts ISD, Roelofs JJ, Sethi S, Suarez R, Zeng C, Seshan SV.
PMID: 35005316
Kidney Int Rep. 2021 Oct 29;7(1):78-86. doi: 10.1016/j.ekir.2021.10.014. eCollection 2022 Jan.

INTRODUCTION: In 2020, a working group of 13 renal pathologists published consensus definitions for 47 individual glomerular lesions found on light microscopy (LM) and 47 glomerular lesions and 9 normal structures found on electron microscopy (EM).METHODS: To test the...

Cite
Haas M, Mirocha J, Amann K, et al. Impact of Consensus Definitions on Identification of Glomerular Lesions by Light and Electron Microscopy. Kidney Int Rep. 2021;7(1):78-86doi: 10.1016/j.ekir.2021.10.014.
Haas, M., Mirocha, J., Amann, K., Bajema, I. M., Barisoni, L., Becker, J. U., Jennette, J. C., Joh, K., Ljubanovic, D. G., Roberts, I. S. D., Roelofs, J. J., Sethi, S., Suarez, R., Zeng, C., & Seshan, S. V. (2022). Impact of Consensus Definitions on Identification of Glomerular Lesions by Light and Electron Microscopy. Kidney international reports, 7(1), 78-86. https://doi.org/10.1016/j.ekir.2021.10.014
Haas, Mark, et al. "Impact of Consensus Definitions on Identification of Glomerular Lesions by Light and Electron Microscopy." Kidney international reports vol. 7,1 (2022): 78-86. doi: https://doi.org/10.1016/j.ekir.2021.10.014
Haas M, Mirocha J, Amann K, Bajema IM, Barisoni L, Becker JU, Jennette JC, Joh K, Ljubanovic DG, Roberts ISD, Roelofs JJ, Sethi S, Suarez R, Zeng C, Seshan SV. Impact of Consensus Definitions on Identification of Glomerular Lesions by Light and Electron Microscopy. Kidney Int Rep. 2021 Oct 29;7(1):78-86. doi: 10.1016/j.ekir.2021.10.014. eCollection 2022 Jan. PMID: 35005316; PMCID: PMC8720667.
Copy Download .nbib Format: NLM
Proteaphagy is specifically regulated and requires factors dispensable for general autophagy.

The Journal of biological chemistry

Waite KA, Burris A, Vontz G, Lang A, Roelofs J.
PMID: 34919962
J Biol Chem. 2021 Dec 14;298(1):101494. doi: 10.1016/j.jbc.2021.101494. Epub 2021 Dec 14.

Changing physiological conditions can increase the need for protein degradative capacity in eukaryotic cells. Both the ubiquitin-proteasome system and autophagy contribute to protein degradation. However, these processes can be differently regulated depending on the physiological conditions. Strikingly, proteasomes themselves...

Cite
Waite KA, Burris A, Vontz G, et al. Proteaphagy is specifically regulated and requires factors dispensable for general autophagy. J Biol Chem. 2021;298(1):101494doi: 10.1016/j.jbc.2021.101494.
Waite, K. A., Burris, A., Vontz, G., Lang, A., & Roelofs, J. (2021). Proteaphagy is specifically regulated and requires factors dispensable for general autophagy. The Journal of biological chemistry, 298(1), 101494. https://doi.org/10.1016/j.jbc.2021.101494
Waite, Kenrick A, et al. "Proteaphagy is specifically regulated and requires factors dispensable for general autophagy." The Journal of biological chemistry vol. 298,1 (2021): 101494. doi: https://doi.org/10.1016/j.jbc.2021.101494
Waite KA, Burris A, Vontz G, Lang A, Roelofs J. Proteaphagy is specifically regulated and requires factors dispensable for general autophagy. J Biol Chem. 2021 Dec 14;298(1):101494. doi: 10.1016/j.jbc.2021.101494. Epub 2021 Dec 14. PMID: 34919962; PMCID: PMC8732087.
Copy Download .nbib Format: NLM
The Diagnostic Value of Language Screening in Primary Progressive Aphasia: Validation and Application of the Sydney Language Battery.

Journal of speech, language, and hearing research : JSLHR

Janssen N, Roelofs A, van den Berg E, Eikelboom WS, Holleman MA, In de Braek DMJM, Piguet O, Piai V, Kessels RPC.
PMID: 34875177
J Speech Lang Hear Res. 2022 Jan 12;65(1):200-214. doi: 10.1044/2021_JSLHR-21-00024. Epub 2021 Dec 07.

PURPOSE: The three variants of primary progressive aphasia (PPA) differ in clinical presentation, underlying brain pathology, and clinical course, which stresses the need for early differentiation. However, brief cognitive tests that validly distinguish between all PPA variants are lacking....

Cite
Janssen N, Roelofs A, van den Berg E, et al. The Diagnostic Value of Language Screening in Primary Progressive Aphasia: Validation and Application of the Sydney Language Battery. J Speech Lang Hear Res. 2021;65(1):200-214doi: 10.1044/2021_JSLHR-21-00024.
Janssen, N., Roelofs, A., van den Berg, E., Eikelboom, W. S., Holleman, M. A., In de Braek, D. M. J. M., Piguet, O., Piai, V., & Kessels, R. P. C. (2022). The Diagnostic Value of Language Screening in Primary Progressive Aphasia: Validation and Application of the Sydney Language Battery. Journal of speech, language, and hearing research : JSLHR, 65(1), 200-214. https://doi.org/10.1044/2021_JSLHR-21-00024
Janssen, Nikki, et al. "The Diagnostic Value of Language Screening in Primary Progressive Aphasia: Validation and Application of the Sydney Language Battery." Journal of speech, language, and hearing research : JSLHR vol. 65,1 (2022): 200-214. doi: https://doi.org/10.1044/2021_JSLHR-21-00024
Janssen N, Roelofs A, van den Berg E, Eikelboom WS, Holleman MA, In de Braek DMJM, Piguet O, Piai V, Kessels RPC. The Diagnostic Value of Language Screening in Primary Progressive Aphasia: Validation and Application of the Sydney Language Battery. J Speech Lang Hear Res. 2022 Jan 12;65(1):200-214. doi: 10.1044/2021_JSLHR-21-00024. Epub 2021 Dec 07. PMID: 34875177.
Copy Download .nbib Format: NLM
Targeting the IL-6-Yap-Snail signalling axis in synovial fibroblasts ameliorates inflammatory arthritis.

Annals of the rheumatic diseases

Symons RA, Colella F, Collins FL, Rafipay AJ, Kania K, McClure JJ, White N, Cunningham I, Ashraf S, Hay E, Mackenzie KS, Howard KA, Riemen AHK, Manzo A, Clark SM, Roelofs AJ, De Bari C.
PMID: 34844926
Ann Rheum Dis. 2022 Feb;81(2):214-224. doi: 10.1136/annrheumdis-2021-220875. Epub 2021 Nov 29.

OBJECTIVE: We aimed to understand the role of the transcriptional co-factor Yes-associated protein (Yap) in the molecular pathway underpinning the pathogenic transformation of synovial fibroblasts (SF) in rheumatoid arthritis (RA) to become invasive and cause joint destruction.METHODS: Synovium from...

Cite
Symons RA, Colella F, Collins FL, et al. Targeting the IL-6-Yap-Snail signalling axis in synovial fibroblasts ameliorates inflammatory arthritis. Ann Rheum Dis. 2021;81(2):214-224doi: 10.1136/annrheumdis-2021-220875.
Symons, R. A., Colella, F., Collins, F. L., Rafipay, A. J., Kania, K., McClure, J. J., White, N., Cunningham, I., Ashraf, S., Hay, E., Mackenzie, K. S., Howard, K. A., Riemen, A. H. K., Manzo, A., Clark, S. M., Roelofs, A. J., & De Bari, C. (2022). Targeting the IL-6-Yap-Snail signalling axis in synovial fibroblasts ameliorates inflammatory arthritis. Annals of the rheumatic diseases, 81(2), 214-224. https://doi.org/10.1136/annrheumdis-2021-220875
Symons, Rebecca A, et al. "Targeting the IL-6-Yap-Snail signalling axis in synovial fibroblasts ameliorates inflammatory arthritis." Annals of the rheumatic diseases vol. 81,2 (2022): 214-224. doi: https://doi.org/10.1136/annrheumdis-2021-220875
Symons RA, Colella F, Collins FL, Rafipay AJ, Kania K, McClure JJ, White N, Cunningham I, Ashraf S, Hay E, Mackenzie KS, Howard KA, Riemen AHK, Manzo A, Clark SM, Roelofs AJ, De Bari C. Targeting the IL-6-Yap-Snail signalling axis in synovial fibroblasts ameliorates inflammatory arthritis. Ann Rheum Dis. 2022 Feb;81(2):214-224. doi: 10.1136/annrheumdis-2021-220875. Epub 2021 Nov 29. PMID: 34844926.
Copy Download .nbib Format: NLM
Proteaphagy is specifically regulated and requires factors dispensable for general autophagy.

The Journal of biological chemistry

Waite KA, Burris A, Vontz G, Lang A, Roelofs J.
PMID: 34919962
J Biol Chem. 2021 Dec 14;298(1):101494. doi: 10.1016/j.jbc.2021.101494. Epub 2021 Dec 14.

Changing physiological conditions can increase the need for protein degradative capacity in eukaryotic cells. Both the ubiquitin-proteasome system and autophagy contribute to protein degradation. However, these processes can be differently regulated depending on the physiological conditions. Strikingly, proteasomes themselves...

Cite
Waite KA, Burris A, Vontz G, et al. Proteaphagy is specifically regulated and requires factors dispensable for general autophagy. J Biol Chem. 2021;298(1):101494doi: 10.1016/j.jbc.2021.101494.
Waite, K. A., Burris, A., Vontz, G., Lang, A., & Roelofs, J. (2021). Proteaphagy is specifically regulated and requires factors dispensable for general autophagy. The Journal of biological chemistry, 298(1), 101494. https://doi.org/10.1016/j.jbc.2021.101494
Waite, Kenrick A, et al. "Proteaphagy is specifically regulated and requires factors dispensable for general autophagy." The Journal of biological chemistry vol. 298,1 (2021): 101494. doi: https://doi.org/10.1016/j.jbc.2021.101494
Waite KA, Burris A, Vontz G, Lang A, Roelofs J. Proteaphagy is specifically regulated and requires factors dispensable for general autophagy. J Biol Chem. 2021 Dec 14;298(1):101494. doi: 10.1016/j.jbc.2021.101494. Epub 2021 Dec 14. PMID: 34919962; PMCID: PMC8732087.
Copy Download .nbib Format: NLM
Three distinct tolerogenic CD14.

Journal of autoimmunity

van Wigcheren GF, Roelofs D, Figdor CG, Flórez-Grau G.
PMID: 33901801
J Autoimmun. 2021 Jun;120:102645. doi: 10.1016/j.jaut.2021.102645. Epub 2021 Apr 23.

Current treatment for patients with autoimmune disorders including rheumatoid arthritis, multiple sclerosis and type 1 diabetes, often consists of long-term drug regimens that broadly dampen immune responses. These non-specific treatments are frequently associated with severe side effects creating an...

Cite
van Wigcheren GF, Roelofs D, Figdor CG, et al. Three distinct tolerogenic CD14. J Autoimmun. 2021;120:102645doi: 10.1016/j.jaut.2021.102645.
van Wigcheren, G. F., Roelofs, D., Figdor, C. G., & Flórez-Grau, G. (2021). Three distinct tolerogenic CD14. Journal of autoimmunity, 120102645. https://doi.org/10.1016/j.jaut.2021.102645
van Wigcheren, Glenn F, et al. "Three distinct tolerogenic CD14." Journal of autoimmunity vol. 120 (2021): 102645. doi: https://doi.org/10.1016/j.jaut.2021.102645
van Wigcheren GF, Roelofs D, Figdor CG, Flórez-Grau G. Three distinct tolerogenic CD14. J Autoimmun. 2021 Jun;120:102645. doi: 10.1016/j.jaut.2021.102645. Epub 2021 Apr 23. PMID: 33901801.
Copy Download .nbib Format: NLM
Showing 181 to 186 of 186 entries